Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Competitive Landscape Professional Research Report 2025

Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Competitive Landscape Professional Research Report 2025

Research Summary

Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) are two important components in the field of cancer research and treatment. CTCs are rare cancer cells that have detached from a primary tumor and entered the bloodstream, enabling them to potentially spread to other parts of the body and form metastatic tumors. CTCs can be isolated from a patient＇s blood sample and used as a liquid biopsy to provide information about the cancer＇s progression and response to treatment. On the other hand, CSCs are a small subset of cancer cells within a tumor that possess self-renewal and differentiation abilities, similar to stem cells. CSCs are believed to be responsible for tumor initiation, growth, and recurrence, as they have the capacity to regenerate the entire tumor. Both CTCs and CSCs are areas of active research, as their detection, isolation, and characterization hold great potential for improving cancer diagnosis, prognosis, and treatment strategies, aiming at more effective therapies and better patient outcomes.

According to DIResearch's in-depth investigation and research, the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.

The major global  manufacturers of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) include Janssen, Qiagen, Advanced Cell Diagnostics, ApoCell, Biofluidica, Clearbridge Biomedics, CytoTrack, Celsee, Fluxion, Gilupi, Cynvenio, On-chip, YZY Bio, BioView, Fluidigm, Ikonisys, AdnaGen, IVDiagnostics, Miltenyi Biotec, ScreenCell, Silicon Biosystems etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs). Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.  

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Include:

Janssen

Qiagen

Advanced Cell Diagnostics

ApoCell

Biofluidica

Clearbridge Biomedics

CytoTrack

Celsee

Fluxion

Gilupi

Cynvenio

On-chip

YZY Bio

BioView

Fluidigm

Ikonisys

AdnaGen

IVDiagnostics

Miltenyi Biotec

ScreenCell

Silicon Biosystems

Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Segment Include:

CTC Enrichment

CTC Detection

CTC Analysis

Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Application Include:

Breast Cancer Diagnosis and Treatment

Prostate Cancer Diagnosis and Treatment

Colorectal Cancer Diagnosis and Treatment

Lung Cancer Diagnosis and Treatment

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Industry PESTEL Analysis

Chapter 3: Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Industry Porter’s Five Forces Analysis

Chapter 4: Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Regional Market Size and Forecast Analysis

Chapter 5: Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Passenger Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources